BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37558203)

  • 21. Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?
    Morita S; Nomura T; Fukushima Y; Morimoto T; Hiraoka N; Shibata N
    Dis Colon Rectum; 2004 Feb; 47(2):227-32. PubMed ID: 15043294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer.
    Lu P; Zhu X; Song Y; Luo Y; Lin J; Zhang J; Cao Y; Huang Z
    Dis Markers; 2022; 2022():7087885. PubMed ID: 35818587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.
    Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H
    Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact and potential predictive role of baseline circulating tumor cells in locally advanced head and neck squamous cell carcinoma.
    Bueno de Oliveira T; Camila Braun A; Ribaldo Nicolau U; Ali Abdallah E; da Silva Alves V; Hugo Fonseca de Jesus V; Fernando Calsavara V; Paulo Kowaslki L; Domingos Chinen LT
    Oral Oncol; 2021 Oct; 121():105480. PubMed ID: 34403888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
    Yuan D; Li K; Zhu K; Yan R; Dang C
    Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocyte-to-monocyte ratio combined with CA19-9 for predicting postoperative recurrence of colorectal cancer in patients with diabetes.
    Yu D; An G; Yao J
    J Clin Lab Anal; 2021 Sep; 35(9):e23944. PubMed ID: 34418175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survival.
    Nicolini A; Ferrari P; Duffy MJ; Antonelli A; Rossi G; Metelli MR; Fulceri F; Anselmi L; Conte M; Berti P; Miccoli P
    Arch Surg; 2010 Dec; 145(12):1177-83. PubMed ID: 21173292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer.
    Carlsson A; Nair VS; Luttgen MS; Keu KV; Horng G; Vasanawala M; Kolatkar A; Jamali M; Iagaru AH; Kuschner W; Loo BW; Shrager JB; Bethel K; Hoh CK; Bazhenova L; Nieva J; Kuhn P; Gambhir SS
    J Thorac Oncol; 2014 Aug; 9(8):1111-9. PubMed ID: 25157764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma.
    Wan S; Kim TH; Smith KJ; Delaney R; Park GS; Guo H; Lin E; Plegue T; Kuo N; Steffes J; Leu C; Simeone DM; Razimulava N; Parikh ND; Nagrath S; Welling TH
    Sci Rep; 2019 Dec; 9(1):18575. PubMed ID: 31819089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study.
    Insua YV; Cámara J; Vázquez EB; Fernández A; Rivera FV; Silva MJVV; Barbazán J; Muinelo-Romay L; Folgar SC; Abalo A; López-López R; Abal M; Alonso-Alconada L
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28608814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.
    Shimada R; Iinuma H; Akahane T; Horiuchi A; Watanabe T
    Oncol Rep; 2012 Apr; 27(4):947-53. PubMed ID: 22267181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enumeration, characterisation and clinicopathological significance of circulating tumour cells in patients with colorectal carcinoma.
    Hamid FB; Lu CT; Matos M; Cheng T; Gopalan V; Lam AK
    Cancer Genet; 2021 Jun; 254-255():48-57. PubMed ID: 33610860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis of the value of circulating tumor cells in monitoring postoperative recurrence and metastasis of colorectal cancer.
    Wu J; Li Z; Zou J; Li L; Cui N; Hao T; Yi K; Yang J; Wu Y
    PLoS One; 2022; 17(9):e0274282. PubMed ID: 36121855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Clinical Diagnostic and Prognostic Value of Preoperative Serum Carcinoembryonic Antigen, CA19-9, and CA24-2 for Colorectal Cancer.
    Hou S; Jing J; Wang Y; Du L; Tian B; Xu X; Sun T; Shi Y
    Altern Ther Health Med; 2023 Sep; 29(6):192-197. PubMed ID: 37295009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies.
    Ye Z; Ding Y; Chen Z; Li Z; Ma S; Xu Z; Cheng L; Wang X; Zhang X; Ding N; Zhang Q; Qian Q
    Cancer Biol Ther; 2019; 20(4):546-551. PubMed ID: 30572767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Application of preoperative serum CYFRA 21-1 level in the prognosis of colorectal cancer].
    Hu WQ; Cong H; Fang RH; Yuan WT; Mao CY; Wang JR; Wang Y; Shi XY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Oct; 57(10):1613-1619. PubMed ID: 37859379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer.
    Chen Y; Yuan J; Li Y; Li X; Yang Y; Li J; Li Y; Shen L
    Hum Cell; 2021 Sep; 34(5):1446-1454. PubMed ID: 34152566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.
    Kaifi JT; Kunkel M; Dicker DT; Joude J; Allen JE; Das A; Zhu J; Yang Z; Sarwani NE; Li G; Staveley-O'Carroll KF; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):690-8. PubMed ID: 25785486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating biomarkers for early detection and clinical management of colorectal cancer.
    Marcuello M; Vymetalkova V; Neves RPL; Duran-Sanchon S; Vedeld HM; Tham E; van Dalum G; Flügen G; Garcia-Barberan V; Fijneman RJ; Castells A; Vodicka P; Lind GE; Stoecklein NH; Heitzer E; Gironella M
    Mol Aspects Med; 2019 Oct; 69():107-122. PubMed ID: 31189073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.